Return to Trial Database

HCRN-MEL89-1

Phase II Study of Daily Oral VP-16 in Previously Untreated Melanoma

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Phase II Study of Daily Oral VP-16 in Metastatic Melanoma

Trial Locations

All sites in which the trial HCRN-MEL89-1 being conducted in.

No data was found